- Home
- BFH vs CGON Comparison
BFH vs CGON Comparison
Compare BFH & CGON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BFH
- CGON
- Stock Information
- Founded
- BFH 1996
- CGON 2010
- Country
- BFH United States
- CGON United States
- Employees
- BFH N/A
- CGON N/A
- Industry
- BFH Business Services
- CGON
- Sector
- BFH Consumer Discretionary
- CGON
- Exchange
- BFH Nasdaq
- CGON NYSE
- Market Cap
- BFH 2.3B
- CGON 2.2B
- IPO Year
- BFH N/A
- CGON 2024
- Fundamental
- Price
- BFH $58.06
- CGON $33.47
- Analyst Decision
- BFH Hold
- CGON Strong Buy
- Analyst Count
- BFH 19
- CGON 8
- Target Price
- BFH $48.94
- CGON $63.88
- AVG Volume (30 Days)
- BFH 758.6K
- CGON 443.7K
- Earning Date
- BFH 10-24-2024
- CGON 11-12-2024
- Dividend Yield
- BFH 1.45%
- CGON N/A
- EPS Growth
- BFH N/A
- CGON N/A
- EPS
- BFH 6.25
- CGON N/A
- Revenue
- BFH $2,467,000,000.00
- CGON $684,000.00
- Revenue This Year
- BFH N/A
- CGON $411.76
- Revenue Next Year
- BFH $1.04
- CGON $405.27
- P/E Ratio
- BFH $9.21
- CGON N/A
- Revenue Growth
- BFH N/A
- CGON 258.12
- 52 Week Low
- BFH $26.58
- CGON $25.77
- 52 Week High
- BFH $63.01
- CGON $50.23
- Technical
- Relative Strength Index (RSI)
- BFH 58.78
- CGON 40.88
- Support Level
- BFH $56.01
- CGON $31.28
- Resistance Level
- BFH $58.40
- CGON $40.47
- Average True Range (ATR)
- BFH 2.18
- CGON 1.91
- MACD
- BFH -0.11
- CGON -0.51
- Stochastic Oscillator
- BFH 59.53
- CGON 23.83
About BFH Bread Financial Holdings Inc.
Formed by a combination of JCPenney's credit card processing unit and The Limited's credit card bank business, Bread Financial is a provider of private label and co-branded credit cards, loyalty programs, and marketing services. The company's most financially significant unit is its credit card business that partners with retailers to jointly market Bread's credit cards to their customers. The company also retains minority interest in its recently spun-off LoyaltyOne division, which operates the largest airline miles loyalty program in Canada and offers marketing services to grocery chains in Europe and Asia.
About CGON CG ONCOLOGY INC
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.